Episode 3: The STREAM2 trial - how should we treat multi-drug resistant tuberculosis?

For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients. Further information is available on the STREAM Stage 2 study page at www.mrcctu.ac.uk and results from STREAM2 are published open access in The Lancet.

For more information and to access the transcript: https://www.mrcctu.ucl.ac.uk//media/2327/stream2-podcast-transcript.docx

Date of episode recording: 2023-03-24
Duration: 00:19:59
Language of episode: English
Presenter:Charlotte Hartley
Guests: Andrew Nunn
Producer: Charlotte Hartley

What is Trial Talk?

The Trial Talk Podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We will get inside trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement is shaping our studies, and discover new ways to run smarter studies.